Viewing StudyNCT00234403



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00234403
Status: COMPLETED
Last Update Posted: 2009-04-23
First Post: 2005-10-05

Brief Title: A Trial to Evaluate the Combination of Iressa Faslodex in Patients With Advanced or Metastatic Breast Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
PR positive breast cancer View
Advanced breast cancer View
Metastatic breast cancer View
ER positive breast cancer View